EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
JAN 2022
TABLES
123
PAGES
179
EDITION
7
PRICE
USD 4950
CODE
MCP10953
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
SELECT PLAYERS
Abcam PLC; Becton, Dickinson and Company; Bio-Rad Laboratories, Inc.; BioTek Instruments, Inc.; Biotium, Inc.; Creative Bioarray; Danaher Corporation; GE Healthcare; Merck KgaA; PerkinElmer, Inc.; Promega Corporation; Thermo Fisher Scientific, Inc.
SEGMENTS
» Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, Other Applications) » End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital and Diagnostic Laboratories, Other End-Uses) » Product Type (Consumables, Instruments)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Impact of Covid-19 and a Looming Global Recession |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
4. GLOBAL MARKET PERSPECTIVE |
World Current & Future Analysis for Cell Viability Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Cell Viability Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Cell Viability Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Basic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Basic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Basic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Stem Cell Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Clinical & Diagnostic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Clinical & Diagnostic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Clinical & Diagnostic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Hospital & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
USA Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
USA Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
USA Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
CANADA |
Canada Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
Canada Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
Canada Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
JAPAN |
Japan Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
Japan Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
Japan Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
CHINA |
China Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
China Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
China Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
EUROPE |
Europe Current & Future Analysis for Cell Viability Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
Europe Historic Review for Cell Viability Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Cell Viability Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
Europe Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
Europe Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
Europe Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
FRANCE |
France Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
France Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
France Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
GERMANY |
Germany Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
Germany Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
Germany Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
ITALY |
Italy Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
Italy Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
Italy Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
UNITED KINGDOM |
UK Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
UK Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
UK Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
REST OF EUROPE |
Rest of Europe Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
Rest of Europe Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
Rest of Europe Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
ASIA-PACIFIC |
Asia-Pacific Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
Asia-Pacific Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
Asia-Pacific Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
REST OF WORLD |
Rest of World Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
Rest of World Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
Rest of World Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
IV. COMPETITION |
Total Companies Profiled: 11 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com